Introduction: Only a few medications are available for the treatment of alcohol use disorders
(AUDs). Areas covered: This paper discusses approved AUD medications, including the …

Alcohol use disorder (AUD), as currently defined in the Diagnostic and Statistical Manual,
5th Edition (DSM–5), is a heterogeneous disorder stemming from a complex interaction of …

Abstract introduction: The number of medications approved for AUD is small and they
generally have limited efficacy. We need new pharmacotherapies for the management of …

Highlights•Alcoholism is a progressive disorder involving several neurotransmitter
systems.•Currently, there are only 3 approved medications.•Nalmefene is pending for …

Compounds known to be successful in the treatment of alcohol use disorder include the
aversive agent, Disulfiram, the glutamatergic NMDA receptor antagonist, Acamprosate, and …

Introduction: At present, the substances acamprosate, naltrexone and disulfiram are
available for pharmacotherapy in alcohol dependence, but clinical studies found only …

The past decade has seen an expansion of research and knowledge on pharmacotherapy
for the treatment of alcohol dependence. The Food and Drug Administration (FDA)-approved …

The psychopharmacology of alcohol dependence is today poised at interesting crossroads.
Three major drugs Naltrexone, Disulfiram and Acamprosate have been tried and tested in …

ContextAlcoholism affects approximately 10% of Americans at some time in their lives.
Treatment consists of psychosocial interventions, pharmacological interventions, or both, but …

Therapeutic interventions to treat alcoholism have increased in number, including several
pharmacotherapies. Aspects of epidemiology, gender, and psychiatric comorbidity as well …